OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis $187.20 +6.61 (+3.66%) As of 01/21/2025 03:18 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsSEC FilingsShort Interest About Cochlear Stock (OTCMKTS:CHEOF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cochlear alerts:Sign Up Key Stats Today's Range$187.20▼$187.2050-Day Range$176.25▼$195.0052-Week Range$163.89▼$237.38Volume5 shsAverage Volume101 shsMarket CapitalizationN/AP/E Ratio114.01Dividend Yield0.68%Price TargetN/AConsensus RatingN/A Company OverviewCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More… Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOF Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)July 26, 2023 | markets.businessinsider.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 20, 2023 | msn.comTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.January 22, 2025 | Stansberry Research (Ad)Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 19, 2023 | benzinga.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 18, 2023 | msn.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)July 10, 2023 | markets.businessinsider.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 10, 2023 | benzinga.comSee More Headlines CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed this year? Cochlear's stock was trading at $182.0528 at the beginning of the year. Since then, CHEOF stock has increased by 2.8% and is now trading at $187.20. View the best growth stocks for 2025 here. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today1/22/2025Next Earnings (Estimated)2/13/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio114.01 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (OTCMKTS:CHEOF) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
